Continuing Medical Education (CME) Credits
Sponsorship Statement: Jointly sponsored by Vanderbilt School of Medicine, Division of Continuing Medical Education, and the INTERNATIONAL CONGRESS ON SCHIZOPHRENIA RESEARCH
Accreditation:
This activity has been planned and implemented in accordance with the Essentials Areas and Policies of the Accreditation Council for CME (ACCME) through the joint sponsorship of Vanderbilt School of Medicine and INTERNATIONAL CONGRESS ON SCHIZOPHRENIA RESEARCH. Vanderbilt School of Medicine is accredited by the Accreditation Council for CME to provide continuing medical education for physicians.
Credit Designation:
Vanderbilt School of Medicine designates this educational activity for a maximum of 31.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Activity Information:
12th International Congress on Schizophrenia Research
28 March – 01 April 2009
Manchester Grand Hyatt
San Diego, California
Topics:
1. Genetic and molecular studies in schizophrenia to update knowledge on pathophysiology and etiology of the illness.
2. Primary treatment data of psychosis in schizophrenia, updating treatment information, and learning new treatment information.
3. How to diagnose, characterize, and treat cognitive dysfunction in schizophrenia from experts in the field
Faculty:
Carol A. Tamminga, MD
S. Charles Schulz, MD
Target Audience:
Attendees are current contributors to the scientific literature and participate actively in poster sessions, oral presentations, and informal exchanges of data, techniques, and ideas.
Disclosure Statement:
It is the policy of Vanderbilt School of Medicine that participants in CME activities be made aware of any affiliation or financial interest that may affect the planner's involvement and speaker's presentation(s). Each course director, planner and speaker has completed and signed a conflict of interest statement. The faculty members' relationships will be disclosed to the audience.